FDA Inspection
QuVa Pharma, Inc.QuVa Pharma, Inc. – FDA Inspection, Jun 16, 2022
Record Details
This FDA Inspection record concerns QuVa Pharma, Inc., with an inspection on June 16, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- QuVa Pharma, Inc.
- Inspection Date
- June 16, 2022
- Product Type
- Drugs
View Company Profile
ID · b5e0dcf1-74fb-430e-9fe3-87ab3c3aad1f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1172047
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.42(c)(10)(i)Floors, walls, ceiling surfaces
- 21 CFR 211.68(b)input/output verification
- 21 CFR 211.186(b)(9)Manufacturing Instructions and Specifications
Full citation text and observation details available on the Dashboard.
Other FDA inspections of QuVa Pharma, Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| March 14, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 20, 2018 | Not classified | Dallas District Office | Drug Quality Assurance |
| December 8, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 23, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 20, 2014 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for QuVa Pharma, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.